Persistent human papillomavirus infection: Definitions and clinical implications

Papillomavirus Report

Volumn 12, Issue 5, 2001, Pages 119-123

  Einstein, M H ^a   Burk, R D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; VIRUS DNA;

ADOLESCENT; ADULT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTORY; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; PATHOLOGY; PERSISTENT INFECTION; PROSPECTIVE STUDY; REVIEW; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0034751919     PISSN: 09574190     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Human papillomaviruses and their possible role in squamous cell carcinomas
2. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: Correlation with biopsy results and Papanicolaou smear
3. Hepatitis B virus. The major etiology of hepatocellular carcinoma
4. The environment and disease: Association or causation?
5. Pernicious papillomavirus infection
6. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica
7. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
8. Immortalization and transformation of human cells by human papillomavirus
9. Utilization of the human genome sequence localizes HPV 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39 year old woman
10. Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa
11. Role of papillomavirus oncogenes in human cervical cancer: Transgenic animal studies
12. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
13. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: Nested case: Control study
14. Taxonomic classification of papillomaviruses
15. Natural history of cervicovaginal papillomavirus infection in young women
16. Human papillomavirus infection is transient in young women: A population-based cohort study
17. Determinants of persistent detection of human papillomavirus DNA in the uterine cervix
18. Transience of cervical HPV infection in sexually active. Young women with normal cervicovaginal cytology
19. Persistence of type-specific human papillomavirus infection among cytologically normal women
20. Follow-up evaluation of human papillomavirus infection in adolescents
21. Effects of ß-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection
22. Persistence of type-specific human papillomavirus infection among cytologically normal women
23. Human papillomavirus DNA in women without and with cytological abnormalities: Results of a 5-year follow-up study
24. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females
25. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
26. Epidemiology of uterine cervical cancer
27. Progressive potential of mild cervical atypia: Prospective cytological, colposcopic, and virological study
28. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study
29. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women
30. Behavior of moderate cervical dysplasia during long-term follow-up
31. Natural history of cervical dysplasia
32. A follow-up study of patients with cervical dysplasia
33. Biologic behavior of dysplasia and carcinoma in situ
34. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load
35. Acute hepatitis B virus infection: Relation of age to the clinical expression of disease and subsequent development of the carrier state
36. Serologic responses in hepatitis B.
37. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
38. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
39. Behavior of mild cervical dysplasia during long-term follow-up
40. Genital human papillomavirus infections. Number 193, June 1994. ACOG technical bulletin
41. Cervical cytology: Evaluation and management of abnormalities. ACOG technical bulletin number 183-August 1993
42. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer
43. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16
44. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells
45. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women